Products

Pomalid 4mg Tablet (Pomalidomide) – Global Supplier & Exporter | Ernest Oncology Pomalid 4mg Tablet Pomalid 4mg Tablet contains Pomalidomide, an advanced immunomodulatory anti-cancer medicine used in the treatment of multiple myeloma, a type of blood cancer affecting plasma cells. This medication helps control cancer progression by modifying the immune system and preventing the growth of abnormal cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Pomalid 4mg tablets to hospitals, cancer treatment centers, pharmaceutical distributors, and international wholesalers worldwide. What is Pomalid 4mg Tablet? Pomalid 4mg Tablet is an immunomodulatory drug (IMiD) that helps the immune system identify and destroy cancer cells. It also prevents the formation of new blood vessels that tumors need to grow. Pomalidomide is usually prescribed in combination with dexamethasone for patients whose multiple myeloma has relapsed or not responded to previous treatments. Mechanism of Action Pomalidomide works through several mechanisms: • Stimulates the immune system to attack cancer cells • Inhibits growth and multiplication of myeloma cells • Prevents formation of blood vessels supplying tumors • Induces apoptosis (programmed death) of cancer cells This combination of actions helps slow the progression of multiple myeloma. Indications Pomalid 4mg Tablet is indicated for the treatment of: • Multiple Myeloma • Relapsed or refractory multiple myeloma • Patients previously treated with lenalidomide and bortezomib It is generally prescribed along with low-dose dexamethasone. Dosage & Administration Typical dosage guidelines: • 4 mg once daily • Taken for 21 days followed by 7 days rest in a 28-day cycle • Capsules should be swallowed whole with water Treatment should be administered under strict supervision of an oncologist. Key Benefits of Pomalid 4mg Tablet ✔ Effective treatment for relapsed multiple myeloma ✔ Strengthens immune response against cancer cells ✔ Helps control tumor progression ✔ Oral capsule therapy for convenient administration ✔ Improves survival outcomes in advanced cases Possible Side Effects Some patients may experience: • Fatigue • Low blood cell counts • Infections • Nausea • Constipation • Peripheral neuropathy Patients should be monitored regularly during treatment. Product Specifications Product Name: Pomalid Generic Name: Pomalidomide Strength: 4 mg Dosage Form: Tablet / Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Agent Packaging: Bottle / Blister Storage: Store below 25°C We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Carfilnat 60mg (Carfilzomib) Injection – Global Supplier & Exporter | Ernest Oncology Carfilnat 60mg Carfilzomib Injection – Targeted Therapy for Multiple Myeloma Treatment Carfilnat 60mg Injection (Carfilzomib) is a modern targeted anti-cancer medication used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. Carfilzomib belongs to the class of medicines called proteasome inhibitors, which disrupt the protein recycling system inside cancer cells and trigger cancer cell death. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Carfilnat 60mg (Carfilzomib) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Carfilnat 60mg (Carfilzomib) Injection? Carfilnat 60mg contains Carfilzomib, a highly selective proteasome inhibitor used primarily for the treatment of relapsed or refractory multiple myeloma. Carfilzomib works by targeting the 26S proteasome enzyme complex, which cancer cells use to break down damaged proteins. By blocking this system, the drug causes the accumulation of toxic proteins inside cancer cells, ultimately leading to programmed cancer cell death (apoptosis). Carfilzomib is widely used in advanced oncology treatment protocols worldwide. Mechanism of Action Carfilzomib works by irreversibly inhibiting the proteasome enzyme system. Its pharmacological actions include: • Blocking the 26S proteasome enzyme complex • Preventing degradation of damaged cellular proteins • Inducing cancer cell apoptosis • Inhibiting tumor cell growth and survival This targeted action makes Carfilzomib an important therapy in multiple myeloma treatment. Medical Uses of Carfilnat 60mg Injection Doctors prescribe Carfilnat (Carfilzomib) for several cancer treatment protocols: Multiple Myeloma Used for relapsed or refractory multiple myeloma patients. Combination Chemotherapy Often used together with other medicines such as: • Dexamethasone • Lenalidomide • Daratumumab These combinations improve treatment outcomes and disease control. Advanced Plasma Cell Cancer Helps slow disease progression in patients with advanced multiple myeloma. Benefits of Carfilnat 60mg (Carfilzomib) Injection • Advanced targeted therapy for blood cancer • Highly effective treatment for multiple myeloma • Blocks proteasome activity in cancer cells • Helps control tumor progression • Widely recommended in international oncology guidelines Product Information Product Name: Carfilnat Injection Generic Name: Carfilzomib Strength: 60 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Proteasome Inhibitor Indication: Multiple Myeloma Prescription: Required Global Demand for Carfilzomib Injection The increasing incidence of multiple myeloma worldwide has significantly increased demand for Carfilzomib targeted therapy injections. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Carfilzomib injection medicines from reliable pharmaceutical exporters in India such as Ernest Oncology. Carfilnat 60mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agenciesWhy Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network across 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast global shipping and logistics • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceutical.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Abirapro 250mg Tablet (Abiraterone Acetate) – Global Supplier & Exporter | Ernest Oncology Abirapro 250mg Tablet Abirapro 250mg Tablet contains Abiraterone Acetate, a targeted anti-cancer medicine used in the treatment of advanced prostate cancer. This medication is commonly prescribed for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, providing Abirapro 250mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Abirapro 250mg Tablet? Abirapro contains Abiraterone Acetate, a medication that reduces the production of androgens (male hormones) in the body. Prostate cancer cells depend on these hormones for growth. By lowering androgen levels, Abirapro helps slow down the progression of prostate cancer. It is often prescribed along with prednisone or prednisolone to improve treatment effectiveness. Mechanism of Action Abiraterone works by inhibiting the enzyme CYP17 (17α-hydroxylase/C17,20-lyase) which plays a key role in androgen production. This mechanism helps: • Reduce testosterone production • Block hormone-driven tumor growth • Slow prostate cancer progression • Improve survival outcomes in advanced prostate cancer Indications Abirapro 250mg Tablet is used in the treatment of: • Metastatic Castration-Resistant Prostate Cancer (mCRPC) • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) • Advanced prostate cancer after failure of other therapies It is generally used in combination with prednisone or prednisolone. Dosage & Administration Typical dosage guidelines: • 1000 mg daily (4 tablets of 250 mg) • Taken once daily on an empty stomach • Should be taken at least 1 hour before or 2 hours after food Treatment must be taken under the supervision of an oncologist. Key Benefits of Abirapro 250mg Tablet ✔ Effective targeted therapy for prostate cancer ✔ Helps slow cancer progression ✔ Reduces testosterone production ✔ Improves overall survival in advanced prostate cancer ✔ Oral tablet therapy for convenient treatment Possible Side Effects Some patients may experience: • Fatigue • High blood pressure • Fluid retention • Joint pain • Low potassium levels • Liver function changes Regular monitoring is recommended during treatment. Product Specifications Product Name: Abirapro Generic Name: Abiraterone Acetate Strength: 250 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Androgen Biosynthesis Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Bortenat 3.5mg (Bortezomib) Injection – Global Supplier & Exporter | Ernest Oncology Bortenat 3.5mg Bortezomib Injection – Targeted Therapy for Multiple Myeloma & Lymphoma Bortenat 3.5mg Injection (Bortezomib) is a powerful targeted anti-cancer medication used primarily for the treatment of multiple myeloma and mantle cell lymphoma. Bortezomib belongs to the class of medicines known as proteasome inhibitors, which work by disrupting the internal protein-regulation system of cancer cells, leading to cancer cell death. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Bortenat 3.5mg (Bortezomib) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major international healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Bortenat 3.5mg (Bortezomib) Injection? Bortenat 3.5mg contains Bortezomib, a targeted chemotherapy medicine designed to inhibit the 26S proteasome, an essential enzyme complex responsible for regulating protein degradation in cells. Cancer cells rely heavily on this proteasome system to survive. By blocking the proteasome, Bortezomib causes the accumulation of damaged proteins within cancer cells, ultimately triggering apoptosis (programmed cancer cell death). Bortezomib has become one of the most widely used treatments for multiple myeloma worldwide. Mechanism of Action Bortezomib works by blocking the proteasome pathway responsible for breaking down cellular proteins. Its actions include: • Inhibition of the 26S proteasome enzyme • Accumulation of damaged proteins inside cancer cells • Induction of apoptosis in malignant plasma cells • Suppression of tumor growth signals Through these mechanisms, Bortezomib significantly helps control the progression of multiple myeloma and lymphoma. Medical Uses of Bortenat 3.5mg Injection Doctors prescribe Bortenat (Bortezomib) for several blood cancer treatments: Multiple Myeloma A first-line treatment for newly diagnosed or relapsed multiple myeloma. Mantle Cell Lymphoma Used in patients with mantle cell lymphoma who have received previous therapy. Combination Chemotherapy Protocols Often used in combination with: • Dexamethasone • Cyclophosphamide • Lenalidomide • Thalidomide These combinations improve the overall effectiveness of treatment. Benefits of Bortenat 3.5mg (Bortezomib) Injection • Highly effective targeted therapy for blood cancers • Standard treatment for multiple myeloma worldwide • Stops abnormal cancer protein regulation • Helps control disease progression • Recommended in international oncology guidelines Product Information Product Name: Bortenat Injection Generic Name: Bortezomib Strength: 3.5 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Proteasome Inhibitor Indication: Multiple Myeloma, Mantle Cell Lymphoma Prescription: Required Global Demand for Bortezomib Injection The increasing incidence of multiple myeloma and lymphoma worldwide has significantly increased demand for Bortezomib targeted therapy injections. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Bortezomib injection medicines from reliable pharmaceutical exporters in India such as Ernest Oncology. Bortenat 3.5mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agenciesWhy Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network across 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast global shipping and logistics • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Capnat 500mg (Capecitabine) Tablet – Global Supplier & Exporter | Ernest Oncology Capnat 500mg Capecitabine Tablets – Oral Chemotherapy Medicine for Breast & Colorectal Cancer Capnat 500mg Tablet (Capecitabine) is an effective oral chemotherapy medicine used in the treatment of several cancers including breast cancer, colorectal cancer, and gastric cancer. Capecitabine belongs to a group of medicines called antimetabolite chemotherapy drugs, which interfere with DNA synthesis in cancer cells, preventing their growth and multiplication. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Capnat 500mg (Capecitabine) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Capnat 500mg (Capecitabine) Tablet? Capnat 500mg contains Capecitabine, an oral prodrug that converts inside the body into 5-Fluorouracil (5-FU), a powerful chemotherapy compound that destroys cancer cells. Unlike traditional chemotherapy injections, Capecitabine allows patients to receive cancer treatment in oral tablet form, improving convenience and treatment compliance. Capecitabine is widely used in modern oncology treatment protocols worldwide. Mechanism of Action Capecitabine works by converting into 5-Fluorouracil (5-FU) inside tumor tissues. Its pharmacological actions include: • Inhibiting DNA synthesis in cancer cells • Blocking tumor cell division • Targeting rapidly growing malignant cells • Slowing tumor growth and metastasis Because tumor cells activate Capecitabine more efficiently than normal cells, the drug provides targeted chemotherapy effects. Medical Uses of Capnat 500mg Tablet Doctors prescribe Capnat (Capecitabine) for several cancer treatments: Colorectal Cancer Used as first-line or adjuvant therapy for colon and rectal cancers. Breast Cancer Commonly prescribed for metastatic breast cancer patients. Gastric Cancer Used in combination with other chemotherapy drugs. Combination Chemotherapy Protocols Often used alongside medicines such as: • Oxaliplatin • Docetaxel • Cisplatin These combinations improve the effectiveness of cancer treatment. Benefits of Capnat 500mg (Capecitabine) Tablet • Effective oral chemotherapy treatment • Used globally for colorectal and breast cancer therapy • Convenient tablet form instead of injection • Helps control tumor progression • Recommended in international oncology guidelines Product Information Product Name: Capnat Tablet Generic Name: Capecitabine Strength: 500 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Antimetabolite Chemotherapy Indication: Breast cancer, colorectal cancer, gastric cancer Prescription: Required Global Demand for Capecitabine Tablets The rising global incidence of breast cancer and colorectal cancer has significantly increased demand for Capecitabine chemotherapy tablets. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Capecitabine tablets from reliable pharmaceutical exporters in India, such as Ernest Oncology. Capnat 500mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast global shipping and logistics • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Glenza 40mg Tablet (Enzalutamide) – Global Supplier & Exporter | Ernest Oncology Glenza 40mg Tablet (Enzalutamide) Glenza 40mg Tablet contains Enzalutamide, an advanced androgen receptor inhibitor used in the treatment of prostate cancer. It is prescribed for men with metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and supplier of oncology medicines, supplying Glenza 40mg tablets to hospitals, distributors, oncology clinics, and pharmaceutical wholesalers worldwide. We ensure genuine pharmaceutical supply, competitive pricing, and reliable global delivery. What is Glenza 40mg Tablet? Glenza 40mg Tablet is a targeted hormonal therapy used in prostate cancer treatment. The medicine works by blocking the androgen receptor signaling pathway, which prostate cancer cells rely on for growth. By inhibiting androgen receptors, Enzalutamide slows the growth and spread of prostate cancer cells, helping to control disease progression and improve patient outcomes. Mechanism of Action Enzalutamide works through multiple mechanisms: • Blocks androgen receptor binding • Prevents androgen receptor nuclear translocation • Inhibits DNA binding of androgen receptors • Stops cancer cell growth stimulated by testosterone This results in reduced tumor growth and delayed disease progression in prostate cancer patients. Indications Glenza 40mg Tablet is indicated for: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Used when prostate cancer continues to progress despite testosterone suppression therapy. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Used in combination with androgen deprivation therapy for advanced prostate cancer. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) Used in patients at high risk of developing metastases. Dosage & Administration Typical dosage: • 160 mg once daily (4 tablets of 40 mg) • Taken with or without food • Tablets should be swallowed whole with water • Treatment should be monitored by an oncologist Key Benefits of Glenza 40mg Tablet ✔ Advanced targeted prostate cancer therapy ✔ Helps delay cancer progression ✔ Improves survival in advanced prostate cancer ✔ Convenient oral tablet treatment ✔ Reduces tumor growth and metastasis risk Possible Side Effects Some common side effects include: • Fatigue • Hot flashes • Hypertension • Headache • Weakness • Decreased appetite Patients should undergo regular monitoring during treatment. Product Specifications Product Name: Glenza Generic Name: Enzalutamide Strength: 40 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Androgen Receptor Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C | We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive wholesale prices ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Bulk order capability ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Complete export documentation Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Packing List • Commercial Invoice • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Bortenat 2mg (Bortezomib) Injection – Global Supplier & Exporter | Ernest Oncology Bortenat 2mg Bortezomib Injection – Targeted Therapy for Multiple Myeloma & Lymphoma Bortenat 2mg Injection (Bortezomib) is a highly effective targeted anti-cancer medicine used in the treatment of multiple myeloma and mantle cell lymphoma. Bortezomib belongs to a class of medicines called proteasome inhibitors, which block the ability of cancer cells to break down proteins required for survival, leading to cancer cell death. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Bortenat 2mg (Bortezomib) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global medical procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Bortenat 2mg (Bortezomib) Injection? Bortenat 2mg contains Bortezomib, a modern targeted chemotherapy medicine used primarily for plasma cell cancers such as multiple myeloma. Bortezomib works by inhibiting the 26S proteasome, an important protein complex that cancer cells rely on to regulate cell survival. Blocking this proteasome causes cancer cells to accumulate damaged proteins and eventually die. Because of its targeted action, Bortezomib has become one of the most important medicines in the treatment of multiple myeloma worldwide. Mechanism of Action Bortezomib acts as a proteasome inhibitor, disrupting cellular protein regulation in cancer cells. Its therapeutic actions include: • Blocking the 26S proteasome enzyme complex • Preventing degradation of damaged proteins • Inducing cancer cell stress and apoptosis • Inhibiting tumor growth and survival pathways Through these mechanisms, Bortezomib effectively slows the progression of multiple myeloma and lymphoma. Medical Uses of Bortenat 2mg Injection Doctors prescribe Bortenat (Bortezomib) for several cancer treatment protocols: Multiple Myeloma A first-line treatment for patients with newly diagnosed or relapsed multiple myeloma. Mantle Cell Lymphoma Used for mantle cell lymphoma patients who have received previous treatments. Combination Chemotherapy Protocols Often used with medicines such as: • Dexamethasone • Cyclophosphamide • Lenalidomide • Thalidomide These combinations improve treatment outcomes in many patients. Benefits of Bortenat 2mg (Bortezomib) Injection • Advanced targeted therapy for blood cancers • Highly effective treatment for multiple myeloma • Stops cancer cell protein regulation • Helps slow disease progression • Widely recommended in international oncology guidelines Product Information Product Name: Bortenat Injection Generic Name: Bortezomib Strength: 2 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Proteasome Inhibitor Indication: Multiple Myeloma, Mantle Cell Lymphoma Prescription: Required Global Demand for Bortezomib Injection The global incidence of multiple myeloma and lymphoma continues to increase, leading to a growing demand for Bortezomib targeted therapy injections. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Bortezomib injection medicines from reliable pharmaceutical exporters in India such as Ernest Oncology. Bortenat 2mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agenciesWhy Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network across 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments.📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Regorafenib (Resihance) 40mg Tablet – Global Supplier & Exporter | Ernest Oncology Regorafenib (Resihance) 40mg Tablet Regorafenib (Resihance) 40mg Tablet is a targeted anti-cancer medication used in the treatment of several advanced cancers including metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer). Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of Regorafenib tablets supplying oncology medicines to hospitals, distributors, and cancer treatment centers worldwide. We provide authentic oncology medicines with complete export documentation, competitive pricing, and reliable global shipping. What is Regorafenib (Resihance) 40mg Tablet? Regorafenib is a multi-kinase inhibitor that works by blocking multiple enzymes involved in tumor growth, cancer cell proliferation, and tumor angiogenesis (blood supply to tumors). By inhibiting these pathways, the medicine helps slow down the growth and spread of cancer cells. Regorafenib is commonly prescribed when other cancer treatments have not been effective. Mechanism of Action Regorafenib targets several protein kinases responsible for tumor progression and angiogenesis. It inhibits: • VEGFR1, VEGFR2, VEGFR3 • KIT • RET • PDGFR • RAF kinases • FGFR By blocking these pathways, Regorafenib helps to: • Stop cancer cell growth • Reduce tumor blood supply • Slow tumor progression • Improve disease control in advanced cancers Indications Regorafenib (Resihance) 40mg Tablet is used for the treatment of: Metastatic Colorectal Cancer (mCRC) For patients whose cancer has progressed after chemotherapy and targeted therapy. Gastrointestinal Stromal Tumors (GIST) Used when other treatments like Imatinib and Sunitinib fail. Hepatocellular Carcinoma (HCC) Used for liver cancer patients previously treated with sorafenib. Dosage & Administration Typical dosage guidelines: • Standard dose: 160 mg once daily (4 tablets of 40 mg) • Taken after a low-fat meal • Treatment cycle: 21 days on treatment + 7 days off Treatment should always be administered under the supervision of an oncologist. Key Benefits of Regorafenib • Targeted cancer therapy • Effective in chemotherapy-resistant cancers • Improves progression-free survival • Reduces tumor blood supply • Suitable for advanced metastatic cancers Possible Side Effects Common side effects may include: • Fatigue • Hand-foot skin reaction • Diarrhea • Hypertension • Loss of appetite • Liver function changes Patients should be monitored regularly during treatment. Product Specifications Product Name: Regorafenib (Resihance) Strength: 40 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Packaging: Blister / Bottle Manufacturer: Oncology Pharmaceutical Manufacturer Storage: Store below 25°C We supply to: • Oncology hospitals • Pharmaceutical distributors • Government tenders • Cancer treatment centers • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive wholesale prices ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Bulk order capability ✔ Global shipping via DHL / FedEx / Aramex ✔ Complete export documentation Export Documentation Provided We provide full export documentation, including • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Product Invoice • Packing List • Batch Release Certificate • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Soratib 200mg (Sorafenib) Tablet – Global Supplier & Exporter | Ernest Oncology Soratib 200mg Sorafenib Tablets – Targeted Therapy for Liver, Kidney & Thyroid Cancer Soratib 200mg Tablet (Sorafenib) is an advanced targeted anti-cancer medicine used in the treatment of several aggressive cancers including hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and differentiated thyroid cancer. Sorafenib belongs to the class of medicines known as multi-kinase inhibitors, which block specific proteins responsible for cancer cell growth and tumor blood vessel formation. Ernest Oncology, a reliable pharmaceutical exporter from India, supplies Soratib 200mg (Sorafenib) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical wholesalers, and global medical distributors across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Soratib 200mg (Sorafenib) Tablet? Soratib 200mg contains Sorafenib, an oral targeted therapy designed to inhibit multiple enzymes involved in cancer growth and angiogenesis (tumor blood vessel formation). Sorafenib works by interfering with the RAF kinase pathway and vascular endothelial growth factor receptors (VEGFR), which are responsible for tumor growth and metastasis. Because of its targeted action, Sorafenib is widely used in modern oncology protocols worldwide. Mechanism of Action Sorafenib functions as a multi-kinase inhibitor, blocking signals that allow cancer cells to grow and spread. Its actions include: • Inhibiting tumor cell proliferation • Blocking angiogenesis (formation of tumor blood vessels) • Targeting RAF kinases and VEGF receptors • Slowing tumor growth and metastasis Through these mechanisms, Sorafenib helps control tumor progression in several aggressive cancers. Medical Uses of Soratib 200mg Tablet Doctors prescribe Soratib (Sorafenib) for several cancer treatments: Liver Cancer (Hepatocellular Carcinoma) One of the most commonly used targeted therapies for advanced liver cancer. Kidney Cancer (Renal Cell Carcinoma) Used to treat advanced kidney cancer when surgery is not possible. Thyroid Cancer Used for radioactive iodine-resistant differentiated thyroid cancer. Advanced Metastatic Tumors Helps control disease progression in advanced cancer stages. Benefits of Soratib 200mg (Sorafenib) Tablet • Advanced targeted therapy for multiple cancers • Blocks tumor blood supply (anti-angiogenic effect) • Slows cancer progression • Improves survival outcomes in liver and kidney cancer • Recommended in international oncology guidelines Product Information Product Name: Soratib Tablet Generic Name: Sorafenib Strength: 200 mg Dosage Form: Tablet Pack Size: 30 Tablets Therapeutic Class: Anti-Cancer / Multi-Kinase Inhibitor Indication: Liver cancer, kidney cancer, thyroid cancer Prescription: Required Global Demand for Sorafenib Tablets The global incidence of liver cancer, kidney cancer, and thyroid cancer continues to rise, increasing the demand for Sorafenib targeted therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Sorafenib tablets from trusted pharmaceutical exporters in India such as Ernest Oncology. Soratib 200mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tendersWhy Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast global shipping and logistics • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Samtica 250mg (Abiraterone Acetate) Tablet – Global Supplier & Exporter | Ernest Oncology Samtica 250mg Abiraterone Acetate Tablets – Advanced Hormone Therapy for Prostate Cancer Samtica 250mg Tablet (Abiraterone Acetate) is a modern targeted hormone therapy medicine used for the treatment of metastatic prostate cancer, particularly metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Abiraterone acetate works by blocking the production of androgens (male hormones) that stimulate prostate cancer growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Samtica 250mg (Abiraterone Acetate) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major international markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Samtica 250mg (Abiraterone Acetate) Tablet? Samtica 250mg contains Abiraterone Acetate, an oral medication that inhibits CYP17 enzyme activity, which is responsible for androgen production in the body. Androgens such as testosterone play a major role in the growth of prostate cancer cells. By blocking androgen production, Abiraterone helps slow tumor progression and improve survival outcomes in prostate cancer patients. This medicine is usually taken along with prednisone as part of a comprehensive hormone therapy protocol. Mechanism of Action Abiraterone works by inhibiting the enzyme CYP17 (17α-hydroxylase/C17,20-lyase), which is essential for androgen biosynthesis. Its pharmacological effects include: • Blocking androgen production in the adrenal glands • Reducing testosterone levels in the body • Preventing stimulation of prostate cancer cells • Slowing tumor growth and disease progression Because of this targeted mechanism, Abiraterone is widely used in modern oncology treatment protocols for prostate cancer. Medical Uses of Samtica 250mg Tablet Doctors prescribe Samtica (Abiraterone Acetate) for several prostate cancer treatment protocols: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Used in patients whose prostate cancer continues to progress despite testosterone suppression therapy. Metastatic Hormone-Sensitive Prostate Cancer Used as part of combination therapy to slow disease progression. Advanced Prostate Cancer Helps reduce tumor growth and improve survival outcomes. Combination Therapy Often prescribed along with prednisone and androgen deprivation therapy (ADT). Benefits of Samtica 250mg (Abiraterone Acetate) Tablet • Advanced hormone therapy for prostate cancer • Reduces androgen hormone production • Slows progression of metastatic prostate cancer • Improves survival rates in advanced cancer patients • Widely recommended in international oncology guidelines Product Information Product Name: Samtica Tablet Generic Name: Abiraterone Acetate Strength: 250 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Hormone Therapy Indication: Metastatic prostate cancer Prescription: Required Global Demand for Abiraterone Acetate Tablets The global incidence of prostate cancer continues to rise, increasing demand for modern treatments such as Abiraterone acetate tablets. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Abiraterone medicines from reliable pharmaceutical exporters in India such as Ernest Oncology. Samtica 250mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network across 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments.📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https

Samluta 40mg (Enzalutamide) Capsule – Global Supplier & Exporter | Ernest Oncology Samluta 40mg Enzalutamide Capsules – Advanced Hormone Therapy for Prostate Cancer Samluta 40mg Capsule (Enzalutamide) is a modern androgen receptor inhibitor used in the treatment of advanced prostate cancer, particularly metastatic castration-resistant prostate cancer (mCRPC). Enzalutamide blocks the activity of male hormones that promote the growth of prostate cancer cells. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Samluta 40mg (Enzalutamide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international healthcare procurement companies across major global markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Samluta 40mg (Enzalutamide) Capsule? Samluta 40mg contains Enzalutamide, an oral anti-androgen targeted therapy used to treat advanced and metastatic prostate cancer. It works by blocking the androgen receptor pathway, which is responsible for stimulating prostate cancer growth. Enzalutamide is commonly prescribed when prostate cancer progresses despite testosterone-lowering treatments. It is widely used in modern oncology treatment protocols for prostate cancer management. Mechanism of Action Enzalutamide works by inhibiting androgen receptor signaling, which plays a major role in prostate cancer progression. Its pharmacological actions include: • Blocking androgen receptors in prostate cancer cells • Preventing testosterone from stimulating tumor growth • Inhibiting cancer cell proliferation • Slowing disease progression in metastatic prostate cancer Because of this targeted action, Enzalutamide therapy significantly improves survival outcomes in prostate cancer patients. Medical Uses of Samluta 40mg Capsule Doctors prescribe Samluta (Enzalutamide) for several prostate cancer treatment protocols including: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Used in patients whose cancer continues to progress despite hormone therapy. Metastatic Hormone-Sensitive Prostate Cancer Helps slow disease progression and improve treatment outcomes. Advanced Prostate Cancer Therapy Used when cancer spreads to other organs such as bones and lymph nodes. Combination Therapy Often used alongside androgen deprivation therapy (ADT). Benefits of Samluta 40mg (Enzalutamide) Capsule • Advanced targeted hormone therapy for prostate cancer • Blocks androgen receptor signaling • Slows cancer progression • Improves survival outcomes in prostate cancer patients • Widely recommended in international oncology guidelines Product Information Product Name: Samluta Capsule Generic Name: Enzalutamide Strength: 40 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Androgen Receptor Inhibitor Indication: Metastatic and advanced prostate cancer Prescription: Required Global Demand for Enzalutamide Capsules The global incidence of prostate cancer continues to rise, increasing demand for advanced therapies such as Enzalutamide capsules. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Enzalutamide medicines from reliable pharmaceutical exporters in India, such as Ernest Oncology. Samluta 40mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network across 100+ countries •GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides full export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Samitib 400mg (Imatinib Mesylate) Tablet – Global Supplier & Exporter | Ernest Oncology Samitib 400mg Imatinib Mesylate Tablets – Targeted Therapy for Leukemia & Gastrointestinal Cancer Samitib 400mg Tablet (Imatinib Mesylate) is an advanced targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GIST). Imatinib belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs) that block abnormal proteins responsible for cancer cell growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Samitib 400mg (Imatinib Mesylate) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international medical procurement companies in major global healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Samitib 400mg (Imatinib Mesylate) Tablet? Samitib 400mg contains Imatinib Mesylate, a targeted therapy designed to block specific enzymes called tyrosine kinases. These enzymes are responsible for uncontrolled cancer cell growth in certain blood cancers and solid tumors. Imatinib revolutionized cancer treatment by specifically targeting abnormal cancer proteins without damaging normal cells as much as traditional chemotherapy. This medicine is widely used in modern oncology protocols worldwide. Mechanism of Action Imatinib works by blocking the activity of specific proteins involved in cancer growth. Key targets include: • BCR-ABL tyrosine kinase in chronic myeloid leukemia • KIT protein in gastrointestinal stromal tumors • PDGF receptors involved in certain rare cancers By inhibiting these proteins, Imatinib: • Prevents cancer cell multiplication • Stops tumor growth signals • Induces cancer cell death • Slows disease progression Because of this targeted mechanism, Imatinib is considered a breakthrough therapy in oncology treatment. Medical Uses of Samitib 400mg Tablet Doctors prescribe Samitib (Imatinib Mesylate) for several cancer treatments including: Chronic Myeloid Leukemia (CML) First-line targeted therapy for patients with Philadelphia chromosome-positive CML. Acute Lymphoblastic Leukemia (ALL) Used in certain Philadelphia chromosome-positive ALL cases. Gastrointestinal Stromal Tumors (GIST) Helps control tumor growth in KIT-positive GIST tumors. Other Rare Tumors Sometimes used in treatment of dermatofibrosarcoma protuberans (DFSP) and other rare cancers. Benefits of Samitib 400mg (Imatinib Mesylate) Tablet • Advanced targeted cancer therapy • Highly effective treatment for leukemia • Blocks cancer growth proteins • Reduces tumor progression in GIST • Improves survival outcomes in cancer patients • Widely recommended in international oncology protocols Product Information Product Name: Samitib Tablet Generic Name: Imatinib Mesylate Strength: 400 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Indication: CML, ALL, GIST and other kinase-driven cancers Prescription: Required Global Demand for Imatinib Mesylate Tablets Imatinib is one of the most widely used targeted oncology medicines worldwide. With the rising incidence of blood cancers and gastrointestinal tumors, the demand for Imatinib medicines continues to grow globally. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica regularly import Imatinib tablets from reliable pharmaceutical exporters in India, such as Ernest Oncology. Samitib 400 mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network across 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast global shipping and logistics • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India🌐 Websites www.oncologymediciensupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor